title: Chemotherapy for advanced epithelial ovarian carcinoma.
abstract: Advanced epithelial ovarian cancer (AOC) is the most common clinical presentation of ovarian cancer. Virtually all patients will require some form of chemotherapy with curative or palliative intent. Prognostic factors, first- and second-line therapy, as well as experimental approaches for AOC are reviewed.
authors.affiliation: Hematology/Oncology Section, Franklin Square Hospital Center, 9000 Franklin Square Drive, Baltimore, Maryland 21237-3998, USA.
authors.forename: Nelson Gustavo Neder
authors.initials: NG
authors.lastname: Kalil
authors.forename: William Patrick
authors.initials: WP
authors.lastname: McGuire
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011379:Prognosis; D012008:Recurrence
chemical_list: D000970:Antineoplastic Agents